X4 Pharmaceuticals, Inc.
Records under this name other than the patents X4 Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 15 patents it holds.
Showing 1 to 10 of 10 · Back to X4 Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,849,169 | MDR E. coli specific antibody Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,206,992 | MDR E. Coli Specific Antibody Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,940,191 | MDR E. coli specific antibody Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,529,405 | MDR E. Coli Immunogen Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 12,274,742 | MDR E. coli immunogen Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 12,103,962 | E. Coli Specific Antibodies Formerly held In force · High confidence | In force | High confidence | |
| US 10,953,003 | Methods for Treating Cancer Formerly held In force · High confidence | In force | High confidence | |
| US 11,357,742 | Methods for Treating Cancer Formerly held In force · High confidence | In force | High confidence | |
| US 11,312,761 | Anti-Respiratory Syncytial Virus Antibodies, and Methods of Their Generation and Use Formerly held In force · High confidence | In force | High confidence | |
| US 11,485,775 | Anti-Respiratory Syncytial Virus Antibodies, and Methods of Their Generation and Use Formerly held In force · High confidence | In force | High confidence |